Other diseases of liver (K76)

The K76 ICD-10 codes represent a group of other diseases of the liver that do not fall under common liver condition categories. These codes cover a variety of specific liver disorders including fatty liver, portal hypertension, and hepatorenal syndrome, helping healthcare providers accurately document diverse liver problems.

The ICD-10 code for fatty liver (K76.0) includes conditions like non-alcoholic fatty liver disease and steatosis of the liver, terms often used interchangeably to describe fat accumulation in liver cells without alcohol involvement. K76.1 codes chronic passive congestion of the liver, sometimes called hepatic congestion or cardiac cirrhosis, which usually results from heart conditions affecting liver blood flow. Codes such as K76.6 represent portal hypertension, a complication seen in liver and systemic diseases. K76.7 identifies hepatorenal syndrome, a serious condition linking liver failure with kidney problems. Additionally, K76.82 covers hepatic encephalopathy; a brain disorder caused by severe liver dysfunction and known by terms like hepatic coma. These codes serve as essential tools for clinicians and coders needing precise classification of less common or complex liver diseases.

Instructional Notations

Type 2 Excludes

A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

  • alcoholic liver disease K70
  • amyloid degeneration of liver E85
  • cystic disease of liver congenital Q44.6
  • hepatic vein thrombosis I82.0
  • hepatomegaly NOS R16.0
  • pigmentary cirrhosis of liver E83.110
  • portal vein thrombosis I81
  • toxic liver disease K71

Clinical Terms

The following clinical terms provide additional context, helping users better understand the clinical background and common associations for each diagnosis listed in this section. Including related terms alongside ICD-10-CM codes supports coders, billers, and healthcare professionals in improving accuracy, enhancing documentation, and facilitating research or patient education.

Hepatic Encephalopathy

A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Hepatic Infarction

Formation of infarct resulting from obstruction of HEPATIC ARTERY and/or PORTAL VEIN most often after LIVER TRANSPLANTATION or hepatobiliary surgery.

Hepatopulmonary Syndrome

A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).

Hepatorenal Syndrome

Functional KIDNEY FAILURE in patients with liver disease, usually LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL), and in the absence of intrinsic renal disease or kidney abnormality. It is characterized by intense renal vasculature constriction, reduced renal blood flow, OLIGURIA, and sodium retention.

Liver Regeneration

Repair or renewal of hepatic tissue.

Peliosis Hepatis

A vascular disease of the LIVER characterized by the occurrence of multiple blood-filled CYSTS or cavities. The cysts are lined with ENDOTHELIAL CELLS; the cavities lined with hepatic parenchymal cells (HEPATOCYTES). Peliosis hepatis has been associated with use of anabolic steroids (ANABOLIC AGENTS) and certain drugs.